Assignee
ARSENAL BIOSCIENCES INC
US·4 granted patents·12 pending applications·7 citations·filing 2021–2025
Top patents by PatentIndex Score
16 records- 0190US11332744B1Safe harbor lociARSENAL BIOSCIENCES INC·Filed 2021·Granted May 17, 2022·4 cites·30 claims
- 0287US12037407B2Immune cells having co-expressed shRNAS and logic gate systemsARSENAL BIOSCIENCES INC·Filed 2023·Granted Jul 16, 2024·2 cites·71 claims
- 0385US11761004B2Safe harbor lociARSENAL BIOSCIENCES INC·Filed 2022·Granted Sep 19, 2023·1 cites·32 claims
- 0472US2024309106A1Immune cells having co-expressed shrnas and logic gate systemsARSENAL BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 0572US2023416747A1Safe harbor lociARSENAL BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 0665US2025049854A1Cells comprising a suppressor of gene expression and/or a syntheticpathway activator and/or an inducible payloadARSENAL BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 0762US2023340409A1Engineered immune cells with priming receptorsARSENAL BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 0861US2024240164A1Non-viral homology mediated end joiningARSENAL BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 0961US2025082682A1Systems of engineered receptors targeting psma and ca9ARSENAL BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 1058US12257304B2Systems targeting PSMA and CA9ARSENAL BIOSCIENCES INC·Filed 2024·Granted Mar 25, 2025·0 cites·61 claims
- 1152US2022235380A1Immune cells having co-expressed shrnas and logic gate systemsARSENAL BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 1249US2023365997A1Compositions and methods of genomic modification of cells and uses thereofARSENAL BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 1344US2025270288A1Synthetic pathway activatorsARSENAL BIOSCIENCES INC·Filed 2025·Application pending·0 cites
- 1444US2025297255A1Systems targeting tmprss4 and slc34a2ARSENAL BIOSCIENCES INC·Filed 2025·Application pending·0 cites
- 1541US2025215438A1Immune cells having co-expressed tgfbr shrnasARSENAL BIOSCIENCES INC·Filed 2025·Application pending·0 cites
- 1639US2025222103A1Immune cells with combination gene perturbationsARSENAL BIOSCIENCES INC·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when ARSENAL BIOSCIENCES INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →